ALEXIS HUSS: Open Payments
NPI 1598247520 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,319 in 126 payments from 21 companies in 2025. Trend: 2023 $861 · 2024 $2,906 · 2025 $2,319
Food & beverage: $2,309Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $764 |
| Aimmune Therapeutics, Inc. | 18 | $269 |
| Janssen Biotech, Inc. | 15 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $178 |
| Ipsen Biopharmaceuticals, Inc | 6 | $121 |
| GENZYME CORPORATION | 4 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $116 |
| Phathom Pharmaceuticals, Inc. | 2 | $112 |
| Ardelyx, Inc. | 6 | $97 |
| Madrigal Pharmaceuticals | 3 | $68 |
Products named: SKYRIZI, ZENPEP, TREMFYA, RINVOQ, ENTYVIO, IQIRVO, XIFAXAN, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
